Confidential mandate
Label Acquisition Synergy and Integration Assumptions Adviser
Planned Hiring / New
Label Acquisition Synergy and Integration Assumptions Adviser mandate in Mumbai, India · Music and Digital Media
A six-month retainer will challenge label acquisition synergy assumptions and integration economics, exposing rights, operating and cultural dependencies while leaving transaction approval, creative choices and financial sign-off with authorised executives.
The mandate
The investment committee's standing question is which label-acquisition synergies can responsibly be included in the financial case when cultural integration and rights economics remain uncertain. The adviser will challenge the assumptions behind value, not recommend creative homogenisation as a convenient cost-saving route. The distinction between an available financial benefit and an integration ambition must remain clear.
Three days monthly cover a selected deal-evidence review, a sponsor challenge and committee attendance. Attendance is included. An acquisition question receives acknowledgement within two working days and a reasoned opinion within four after the authorised records arrive. Continuous diligence execution and negotiation support are outside this retainer.
The six-month appointment begins on 19 October 2026. The committee chair may renew only where the acquisition agenda continues to need independent assumptions challenge and conflict conditions remain acceptable. The adviser holds no line authority over labels, and carries no executive responsibility for transactions or integration. Internal finance, legal and creative leaders retain their decisions and signatures.
The sponsor supplies anonymised synergy models, rights obligations and integration plans. Advice should test whether savings depend on changes that could impair revenue or creative relationships, and whether territorial benefits are contractually available. Where evidence cannot establish a cultural or commercial response, the adviser should frame a staged hypothesis rather than place an unsupported benefit in the base case.
Concurrent independent advice is permitted. Relationships with a selling label, competing buyer, artist representative or transaction adviser may create a conflict requiring disclosure and recusal. Rights legal opinions, valuation certification and integration management are excluded. The committee wants a finance practitioner's independent voice, not an endorsement that masks uncertainty or an adviser whose fee depends on completing the deal.
What you will own
- Challenge synergy inclusion by tracing the rights and operating prerequisites, pressing sponsors to distinguish an available benefit from one contingent on unverified integration behaviour.
- Test cost-saving assumptions for adverse revenue or relationship effects, advising where financial efficiency may weaken the asset the acquisition is intended to preserve.
- Shape staged benefit cases that retain cultural and territorial uncertainty, avoiding the false precision of assigning every integration ambition to the base valuation.
- Examine whether cross-territory benefits are permitted by rights and reporting arrangements, relying on authorised legal interpretation rather than giving an independent legal opinion.
- Press sponsors to identify benefit ownership after close, ensuring the acquisition case can be compared with realised financial evidence rather than rewritten retrospectively.
- Review downside options where integration cannot proceed as assumed, advising what can be learned or changed before further irreversible commitments are made.
- Record independent recommendations and evidence gaps in a synergy note, leaving acquisition approval, creative direction and binding integration action with internal leaders.
Candidate qualifications
- Evidence acquisition-finance or strategic finance judgement in music, media or another rights-based business. Explain a synergy assumption you challenged and the rights or operating prerequisite that altered the investment view.
- Demonstrate post-close benefit analysis rather than only pre-deal modelling. Candidates should describe how realised effects differed from the original case and how that evidence improved subsequent acquisition assumptions.
- Show ability to examine cultural integration without pretending it can be reduced to a simple saving percentage. Provide a case where relationship or revenue consequences changed the financial recommendation.
- Evidence independence from selling parties, buyers and transaction incentives. Describe a disclosed relationship, recusal or opinion that resisted a sponsor's desire for endorsement while maintaining useful advice.
- Provide a decision-ready synergy note with sources, uncertainty and reconsideration triggers. Reserve three sustainable days monthly and demonstrate acquisition-finance judgement through a source-linked comparison of expected integration benefits with realised territorial reporting. Candidates should explain how legal advice was incorporated without being presented as their own certification, and how confidential rights material remained separated from concurrent mandates. Explain how you tested a synergy dependent on retaining a creative relationship without claiming that finance could control that relationship. The recommendation should identify the measurable financial evidence, the unresolved behavioural assumption and the stage at which stronger confidence would be justified.
Application
Applications for this mandate are received in one way only: through the India Board Terminal's application process. It is automated end to end. Your Executive Passport travels to the mandate holder in its confidential form, your answers to the three questions below are read before anything else in your file, and every stage that follows is recorded on your applications page.
There is no address to write to and no intermediary to call. The mandate holder reads what the Terminal delivers and nothing else, which is what keeps the process the same for every applicant and keeps your name out of it until you release it. Applications close on 12 October 2026. Mandate reference PCT-ADV-2026-IND-13.
More seats like this one
This mandate is confidential. The client is named only under a mutual NDA, and your own record is never listed, sold or shown to a company under your name until you release it for this specific mandate.